Target intelligence / Profile preview

TLE family member 5, transcriptional modulator (TLE5)

Target
TLE5
Molecular classification
Transcriptional corepressor, Transcription factor modulator, Groucho/TLE family
01

Overview

TLE family member 5, also known as TLE5 or Amino-terminal enhancer of split (AES), is a member of the Groucho/transducin-like enhancer of split (TLE) family of transcriptional corepressors[1][2][4]. Unlike the long TLE family members (TLE1–4), TLE5 is a short isoform lacking the WD repeat domain and functions primarily as a dominant negative regulator by binding to the Q domain of long TLE proteins and preventing tetramer formation, thus modulating their ability to repress target gene expression[1]. TLE5 also has independent roles: it participates in the negative regulation of NF-κB and androgen receptor target gene expression, modulates Wnt and Notch signaling pathways, and is essential for proper cell fate determination and differentiation. Loss of TLE5 function has been linked to enhanced tumor invasiveness and metastasis in several cancers and is associated with drug resistance[1][4]. No drugs are currently available that directly target TLE5, but inhibitors of related signaling pathways may modulate its activity or stability in disease contexts.

Other names
AESAmino-terminal enhancer of splitGRG5Groucho-related protein 5ESP1Gp130-associated protein GAMProtein GRGProtein ESP1TLE5Amino enhancer of splitGRGAES-1AES-2TLE family member 5amino-terminal enhancer of split
02

Mechanism of action

Dominant negative inhibition of long TLE members (suppresses TLE tetramer formation); corepression of gene expression via interaction with transcription factors (e.g., TCF/LEF1 in Wnt pathway, HES1 in Notch, and AR in androgen signaling); recruitment (or interference with recruitment) of HDACs for transcriptional suppression[1][2][4]

03

Biological functions

Transcriptional repressionModulation of Wnt signalingModulation of Notch signalingCell differentiationRegulation of NF-κB-regulated gene expressionSuppression of androgen receptor signaling
04

Disease associations

Cancer (suppressor in colorectal, prostate, and other cancers)Developmental disordersGranulomatous gastritisArthrogryposis distal type 1A
05

Safety considerations

No specific clinical safety concerns identified for direct targeting; potential concern if broadly modulating core transcriptional repression in normal tissues[1]
06

Interacting drugs

No approved or clinical-stage drugs directly targeting TLE5 reported in current data; CK1 inhibitors may affect TLE5 stability indirectly in cancer[1]
07

Biomarkers

Loss of TLE5 expression is associated with metastasis and drug resistance in colorectal, breast, prostate, and ovarian cancers[1]

Beyond the preview

Go deeper on TLE family member 5, transcriptional modulator (TLE5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TLE family member 5, transcriptional modulator (TLE5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call